Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Duration of premix lispro insulin maintenance after short-term intensive insulin therapy in newly diagnosed type 2 diabetes
ChiCTR-TRC-10001618Phase 4Completed
- Sponsor
- Sun Yat-sen Memorial Hospital
- Start
- Oct 2010
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of insulin lispro + insulin lispro protamine in type 2 diabetes mellitus (T2DM) (4 arms), sponsored by Sun Yat-sen Memorial Hospital. Primary endpoints: AUCi, HOMA-beta and 2 more. Started Oct 2010; status: completed.
02
Drugs
insulin lispro + insulin lispro protamine
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on ChiCTR-TRC-10001618.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-10001618.